Nicotine Lozenge Bioequivalence Study

Clinical trial NCT01536704 · COMPLETED

Trial details

NCT number: NCT01536704
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2011-07-01
Primary completion: 2011-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.